Drugs / INS117548
last change May 2009 re-read 3 minutes ago

INS117548

Developed for
glaucoma
Investigated by
Merck Sharp & Dohme LLC

Trials 1

2009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT00767793 Sep 2008 → May 2009 glaucoma Merck Sharp & Dohme LLC Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as INS117548 ClinicalTrials.gov intervention name — accepted as the source's own label NCT00767793 ↗